Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=7
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=7
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=7
PubPharm (1.074)
61
A trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients hospitalised with moderate COVID-19 : A randomised, double-blind, placebo-controlled, Phase III trial to determine the efficacy and safety of inhaled SNG001 for the treatment of patients hospitalised due to moderate COVID-19 - SPRINTER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
62
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
63
A Phase 2/3 Randomized, Double blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Prevention of COVID 19 : A Phase 2/3 Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Prevention of COVID-19 (EVADE) - ADG20-PREV-001
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
64
COVID-19 Antibody Responses in Cystic Fibrosis: CAR-CF : COVID-19 Antibody Responses in Cystic Fibrosis: CAR-CF - CAR-CF
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
65
Safety and immunogenicity of an additional dose of a candidate recombinant protein vaccine against COVID-19 in people with varying degrees of immunosuppression. : A Phase III, open label, single arm, multi-center, trial to assess the immunogenicity and safety of an additional dose vaccination with a recombinant protein RBD fusion heterodimer candidate (PHH-1V) against SARS-CoV-2, in adults with pre-existing immunosupressive conditions vaccinated against COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
66
Population-based study on efficacy and safety of a booster COVID-19 vaccination : Population-based prospective, clinical study on efficacy and safety of a booster COVID-19 vaccination - VAC3 COVID-19 antibody study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
67
COVID-19: Immune response in patients with cancer undergoing mRNA vaccination against SARS-CoV-2. I-SPARC study : COVID-19: Immune response in patients with cancer undergoing mRNA vaccination against SARS-CoV-2. I-SPARC study - I-SPARC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
68
A trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients hospitalised with moderate COVID-19 : A randomised, double-blind, placebo-controlled, Phase III trial to determine the efficacy and safety of inhaled SNG001 for the treatment of patients hospitalised due to moderate COVID-19 - SPRINTER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
69
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
70
A Phase 2/3 Randomized, Double blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Prevention of COVID 19 : A Phase 2/3 Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Prevention of COVID-19 (EVADE) - ADG20-PREV-001
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
[1]
« Vorheriger
2
3
4
5
6
7
8
9
10
11
12
Nächster »
[108]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
1.074
Aufsätze
1.074
E-Artikel
1.074
E-Ressourcen
Zeitschriftentitel
1.074
WHO International Clinical Trials Registry Plat...
Thema
1.074
610
1.074
Recruitment Status: Authorised-recruitment may ...
1.074
Study Type: Interventional
484
Phase: Phase 2
314
Phase: Phase 3
220
Phase: Phase 4
56
Phase: Phase 1
38
Medical Condition: COVID-19;Therapeutic area: D...
14
Medical Condition: Acute respiratory distress s...
14
Medical Condition: Protection against COVID-19 ...
12
Medical Condition: COVID-19 MedDRA version: 23....
12
Medical Condition: COVID-19 MedDRA version: 23....
12
Medical Condition: COVID-19 MedDRA version: 23....
12
Medical Condition: COVID-19 infection MedDRA ve...
12
Medical Condition: Coronavirus Disease 2019 (CO...
10
Medical Condition: COVID-19 MedDRA version: 23....
10
Medical Condition: COVID-19;Therapeutic area: D...
10
Medical Condition: Healthy Volunteers, with or ...
10
Medical Condition: Moderate to severe coronavir...
10
Medical Condition: moderate COVID-19 infection ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
32
2023
236
2022
426
2021
380
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.042
Englisch
26
Unbestimmt
2
Französisch
2
Deutsch
2
Polnisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...